As Price Falls, Vetr Upgrades GlaxoSmithKline To Buy By: Benzinga via Benzinga April 20, 2017 at 14:35 PM EDT The Vetr crowd on Thursday upgraded its rating for GlaxoSmithKline plc (ADR) (NYSE: GSK) from 3 stars (Hold), issued 527 days ago, to 4 ... Read More >> Related Stocks: Gsk Plc ADR